GlassScriptPhysician profile
Nora A Taha
NPI 1962632695
$5,242.05
in general payments reported to CMS, 2019-2025
25 companies · $168 in 2025
The $168 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,505 · 2020: $467 · 2021: $902 · 2022: $509 · 2023: $239 · 2024: $451 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $858.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,595.41 | 2019-2025 | Eterna, Cardiomems |
| Vertos Medical, INC. | $1,366.11 | 2019-2022 | |
| Nevro Corp. | $529.79 | 2019-2021 | |
| Medtronic, INC. | $497.35 | 2021-2025 | Intellis Adaptivestim |
| Collegium Pharmaceutical, INC. | $328.08 | 2019-2025 | Belbuca, Xtampza |
| Boston Scientific Corporation | $170.00 | 2019-2021 | |
| Abbvie INC. | $139.74 | 2022-2025 | Botox |
| Stratus Medical, LLC | $74.18 | 2020 | |
| Arbor Pharmaceuticals, INC. | $68.19 | 2019-2021 | |
| Spr Therapeutics, INC | $66.30 | 2023-2024 | Sprint Pns System |
| Depuy Synthes Sales INC. | $63.05 | 2019-2024 | Orthovisc |
| Allergan, INC. | $49.84 | 2019 | |
| Pfizer INC. | $40.74 | 2019 | |
| Scilex Pharmaceuticals INC. | $39.74 | 2019-2023 | Ztlido |
| Biodelivery Sciences International, INC. | $39.73 | 2020-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $29.71 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $22.48 | 2024 | Iovera, Zilretta |
| Vertiflex, INC. | $22.48 | 2019 | |
| Azurity Pharmaceuticals, INC. | $17.46 | 2024 | Horizant |
| Almatica Pharma LLC | $14.82 | 2022 | |
| Shionogi INC | $14.38 | 2019 | |
| Ibsa Pharma INC. | $14.23 | 2023 | Licart, Tirosint |
| Curonix LLC | $13.58 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Assertio Therapeutics, INC. | $12.55 | 2019 | |
| Orthogenrx INC. | $12.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nora Taha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.